EBIT: Income before interest and taxes.
Edesa Biotech, Inc. (EDSA) had EBIT of $-4.30M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-4.22M |
|
-- |
|
-- |
|
$4.30M |
|
$-4.30M |
|
$0.08M |
|
$-4.22M |
|
$-4.22M |
|
$-4.22M |
|
$-4.22M |
|
$-4.22M |
|
$-4.22M |
|
|
EBIT |
$-4.30M |
$-4.27M |
|
8.54M |
|
8.54M |
|
$-0.49 |
|
$-0.49 |
|
| Balance Sheet Financials | |
$10.42M |
|
-- |
|
$1.97M |
|
$12.38M |
|
$2.19M |
|
-- |
|
-- |
|
$2.19M |
|
$1.82M |
|
$8.27M |
|
$10.20M |
|
8.89M |
|
| Cash Flow Statement Financials | |
$-4.10M |
|
-- |
|
$3.35M |
|
$10.79M |
|
$10.00M |
|
$-0.79M |
|
$0.88M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.76 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.10M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-231.52% |
|
-51.01% |
|
-34.06% |
|
-41.37% |
|
$1.15 |
|
$-0.48 |
|
$-0.48 |
|